SARS-CoV-2 immunoglobulin G (IgG) antibody IVD, control
- Device ID
- 148663
- MHRA Reference Number
- 148663
- Date Registered
- Nov 26, 2024
- Last Updated
- Nov 19, 2024
- Device Type
- In Vitro Diagnostic Device
- Devices
- SARS-CoV-2 immunoglobulin G (IgG) antibody IVD, control
- Type
- IVD General
- Address
- 495 Enterprise Street San Marcos, California, United States
- Created Date
- May 27, 2022
- Relationship Type
- UK Responsible Person
- Address
- 7 CAMPION WAY BINGHAM, NOTTINGHAM, England, United KingdomPostcode: NG13 8 TR
Devices with a matching generic name or device type registered with MHRA
Additional devices registered by the same manufacturer
Additional devices represented by UKCApartner4U Limited in the UK
SARS-CoV-2 immunoglobulin G (IgG) antibody IVD, control is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 148663. The device is manufactured by Cliniqa Corporation from United States, classified as In Vitro Diagnostic Device. The authorized representative in the UK is UKCApartner4U Limited.
This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, authorized representative details, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.